APA

Corbin A. E., Meltzer L. T., Ninteman F. W., Wiley J. N., Christoffersen C. L., Wustrow D. J., Wise L. D., Pugsley T. A. & Heffner T. G. (20000815). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects. : Neuropharmacology.

Chicago

Corbin A E, Meltzer L T, Ninteman F W, Wiley J N, Christoffersen C L, Wustrow D J, Wise L D, Pugsley T A and Heffner T G. 20000815. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects. : Neuropharmacology.

Harvard

Corbin A. E., Meltzer L. T., Ninteman F. W., Wiley J. N., Christoffersen C. L., Wustrow D. J., Wise L. D., Pugsley T. A. and Heffner T. G. (20000815). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects. : Neuropharmacology.

MLA

Corbin A E, Meltzer L T, Ninteman F W, Wiley J N, Christoffersen C L, Wustrow D J, Wise L D, Pugsley T A and Heffner T G. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects. : Neuropharmacology. 20000815.